Zoltan Szallasi

Overview

Best Publications

• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  Marco Gerlinger;Andrew J. Rowan;Stuart Horswell;James Larkin

  8405
  Citations

• An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

  Balazs Györffy;Andras Lanczky;Aron C. Eklund;Carsten Denkert

  3315
  Citations

• The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

  Leming Shi;Laura H. Reid;Wendell D. Jones;Richard Shippy

  2470
  Citations

• Tracking the Evolution of Non–Small-Cell Lung Cancer

  Mariam Jamal-Hanjani;Gareth A. Wilson;Nicholas McGranahan;Nicolai Juul Birkbak

  2216
  Citations

• Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

  Christopher Abbosh;Nicolai J. Birkbak;Nicolai J. Birkbak;Gareth A. Wilson;Gareth A. Wilson;Mariam Jamal-Hanjani

  1956
  Citations

• A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers

  Scott L Carter;Aron C Eklund;Aron C Eklund;Isaac S Kohane;Lyndsay N Harris

  1374
  Citations

• Robustness of cellular functions

  Jörg Stelling;Uwe Sauer;Zoltan Szallasi;Francis J. Doyle

  1307
  Citations

• Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

  Daniel P. Silver;Andrea L. Richardson;Aron C. Eklund;Zhigang C. Wang

  1254
  Citations

• Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

  Elza C. de Bruin;Nicholas McGranahan;Nicholas McGranahan;Richard Mitter;Max Salm

  1193
  Citations

• Neoantigen-directed immune escape in lung cancer evolution

  Rachel Rosenthal;Rachel Rosenthal;Elizabeth Larose Cadieux;Roberto Salgado;Maise Al Bakir

  937
  Citations

• Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

  Melinda L. Telli;Kirsten M. Timms;Julia Reid;Bryan Hennessy

  904
  Citations

• Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

  Balázs Győrffy;András Lánczky;Zoltán Szállási

  847
  Citations

• Reliability and reproducibility issues in DNA microarray measurements

  Sorin Draghici;Purvesh Khatri;Aron C. Eklund;Zoltan Szallasi

  772
  Citations

• Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data

  Francesco Favero;Tejal Joshi;Andrea Marion Marquard;Nicolai Juul Birkbak

  722
  Citations

• Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

  Nicholas McGranahan;Nicholas McGranahan;Francesco Favero;Elza C. de Bruin;Nicolai Juul Birkbak;Nicolai Juul Birkbak

  684
  Citations

• Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents

  Nicolai J. Birkbak;Nicolai J. Birkbak;Zhigang C. Wang;Zhigang C. Wang;Ji Young Kim;Aron C. Eklund

  583
  Citations

• Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

  Samra Turajlic;Samra Turajlic;Hang Xu;Kevin Litchfield;Andrew Rowan

  578
  Citations

• Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells.

  K Ozawa;Z Szallasi;M G Kazanietz;P M Blumberg

  535
  Citations

• Chromosomal Instability Confers Intrinsic Multidrug Resistance

  Alvin J. X. Lee;David Endesfelder;Andrew J. Rowan;Axel Walther

  526
  Citations

• Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

  Thomas J. Mitchell;Samra Turajlic;Andrew Rowan;David Nicol

  474
  Citations